Business Wire

NTT Com Wins Two MEF 3.0 Proof of Concept Awards

21.11.2019 09:03:00 EET | Business Wire | Press release

Share

NTT Communications Corporation (NTT Com), the ICT solutions and international communications business within the NTT Group (TOKYO: 9432), announced today it received MEF 3.0 Proof of Concept Awards in two categories, “MEF3.0 SD-WAN Implementation 2019” and “Network Slicing Implementation 2019,” during the MEF 3.0 Proof of Concept Showcase event held in the U.S. city of Los Angeles from November 18 to 22.

The showcase was organized by the Metro Ethernet Forum (MEF), a global telecom industry alliance with more than 220 members. NTT Com attended the showcase to introduce an SD-WAN1 service and a 5G-related proof of concept (PoC)2, joining other telecom carriers and manufacturers that presented their own initiatives for judging.

About MEF Awards
https://www.mef.net/2019_MEF_Awards

MEF3.0 SD-WAN Implementation 2019
NTT Com’s orchestrated virtualized multivendor SD-WAN services received the award presented for the best SD-WAN service in compliance with MEF specifications. The NTT Com service was recognized for enabling lifecycle3 management and operation of multiple SD-WAN products with a unified portal and white box CPEs4.

SD-WAN is not a standardized technology, so many unique network devices exist, requiring operation methods to be designed to each manufacturer’s technologies. To solve this problem, NTT Com conducted a PoC to implement unified control of multiple SD-WAN products based on MEF-standardized SD-WAN specifications, data models, interfaces and test methods.

NTT Com collaborated with partner companies to co-develop the orchestrated virtualized multivendor SD-WAN services in conformance with the MEF70 and MEF SD-WAN Presto API standard5. The service uses a universal CPE platform, enabling multiple SD-WAN products to be installed on the white box CPE, and a unified configuration portal, enabling unified control of multiple SD-WAN products.

The partner companies involved in co-development are ADVA, Netcracker Technology, Silver Peak, Spirent Communications, Versa Networks and NEC Corporation.

Network Slicing Implementation 2019
The award for the best network slicing6 technology was presented to NTT Com collaborating with partner companies for its 5G xHaul Sharing Slices with LSO Orchestration, which enables automatic control by using network slices for multiple-operator interconnection.

5G technology is anticipated to be used in companies and local governments in addition to telecom carriers by utilizing to such as private 5G service. The new network system that the various companies can use in common like this is necessary to build the network effectively.

NTT Com collaborated with partner companies to co-develop the shared xHaul architecture in conformance with the MEF standard by utilizing network slicing technology.
The architecture creates end-to-end network slices by multi-operator collaboration to share the access network (xHaul) required for 5G service.

The partner companies that contributed to the solution are NTT Corporation and Okinawa Open Laboratory.

SDN7 and network functions virtualization (NFV)8 technologies continue to be advanced through open-source development projects and by standardization organizations. Going forward, NTT Com aims to help drive the development of SDN and NFV technologies through its participation in MEF and ONF9.

1:

SD-WAN simplifies the management and operation of a WAN by separating the networking hardware from its control mechanism.

2:

Verification and demonstration of prototype development to demonstrate new concepts, theories, principles and ideas for commercialization and service development

3:

Service provision process covering application, start of use, settings and quality control

4:

Separates CPE hardware and software functions and allows software selection and installation for each application

5:

MEF specification for SD-WAN: https://www.mef.net/resources/technical-specifications/download?id=122&fileid=file1

6:

Virtual division of network according to characteristics, such as low latency, wide bandwidth or high reliability, by application purpose

7:

Technologies that dynamically control network configuration and settings using software

8:

Method for operating network devices as software on virtualized infrastructure of general-purpose servers

9:

Open Networking Foundation, which standardizes SDN technologies and develops open source software

Related links

About NTT Communications
NTT Communications solves the world's technology challenges by helping enterprises overcome complexity and risk in their ICT environments with managed IT infrastructure solutions. These solutions are backed by our worldwide infrastructure, including industry leading, global tier-1 public and private networks reaching over 190 countries/regions, and more than 450,000m2 of the world's most advanced data center facilities. Our global professional services teams provide consultation and architecture for the resiliency and security required for your business success, and our scale and global capabilities in technology world are unsurpassed. Combined with NTT Ltd., NTT Data, and NTT DOCOMO, we are NTT Group.
www.ntt.com | Twitter@NTT Com | Facebook@NTT Com | LinkedIn@NTT Com

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

For more information
Ryu Kanishima
Service Strategy Department
NTT Communications
Mail: mgr-nwcore-td@ntt.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 21:00:00 EET | Press release

Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham, MSc, MD, FRCPC, dermatologist, SKiN Centre for Dermatology, Peterborough, Ontario, Canada, principal investigator for the Latitude PsO studies and presenting author. “These efficacy and safety results show it’s possible for a once-daily pill to deliver rapid, lasting skin clearance, highlighting the potential of zasoc

Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 21:00:00 EET | Press release

Incyte (Nasdaq:INCY) today announced 54-week data evaluating the safety and efficacy of povorcitinib (INCB54707), an oral small-molecule highly-selective JAK1 inhibitor, from the pivotal Phase 3 STOP-HS clinical trial program in adult patients (≥18 years) with moderate to severe hidradenitis suppurativa (HS). The late-breaking oral presentation of these data is taking place at the 2026 American Academy of Dermatology (AAD) Annual Meeting, being held March 27-31, 2026, in Denver (Session: S034 – Late-Breaking Research: Session 2. Saturday, March 28, 2026, 1:00-4:00 p.m. MT). “The 54-week results from the STOP-HS program deliver compelling, long-term evidence supporting the potential of povorcitinib for patients with moderate to severe HS,” said Pablo J. Cagnoni, M.D., President and Global Head of Research and Development, Incyte. “Across both studies, povorcitinib demonstrated substantial and durable improvements over time in key measures of treatment success and meaningful clinical ben

AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 17:00:00 EET | Press release

Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-breaking session at the 2026 American Academy of Dermatology (AAD) Annual Meeting. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260328320362/en/ Atopic dermatitis is the most common inflammatory skin disorder in children, yet treatment options in the moderate-to-severe pediatric setting are limited.5 The disease can have a significant impact on quality of life for both the patients and their loved ones, with persistent itch and recurrent skin lesions often disrupting sleep, school and relationships.5-8 “Atopic dermatitis can affect many aspects of children’s lives including schoolwork, emotional development

Angelalign Technology (6699.HK) Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 21:56:00 EET | Press release

Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti

Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 19:46:00 EET | Press release

Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye